Laura Coates
0000-0002-4756-663X
Oxford University
76 papers found
Refreshing results…
What influences patients’ opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group
Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study
GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting
Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
A Multicentre Observational Psoriatic Arthritis Cohort Study Addressing Real-life Outcomes of a Treat to Target Approach in Routine Clinical Practice.
Clinical effectiveness of symptomatic therapy compared with standard step-up care for the treatment of low-impact psoriatic oligoarthritis: the two-arm parallel group randomised POISE feasibility study
To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort study
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis–Correction
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
Comparing the Visual Analog Scale and the Numerical Rating Scale in Patient-reported Outcomes in Psoriatic Arthritis
Determinants of Patient‐Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association WithSex in 458 Patients From Fourteen Countries
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update
Measuring Outcomes in Psoriatic Arthritis
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta‐analysis
Missing publications? Search for publications with a matching author name.